These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 29447417

  • 1. Primary Central Nervous System Lymphoma-PART 1: Epidemiology, Diagnosis, Staging, and Prognosis.
    Lukas RV, Stupp R, Gondi V, Raizer JJ.
    Oncology (Williston Park); 2018 Jan 15; 32(1):17-22. PubMed ID: 29447417
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Diagnosis, prognosis and treatment of primary central nervous system lymphoma in the elderly population (Review).
    Liu Y, Yao Q, Zhang F.
    Int J Oncol; 2021 Mar 15; 58(3):371-387. PubMed ID: 33650642
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Histopathology, pathogenesis and molecular genetics in primary central nervous system lymphomas.
    Nakamura M, Shimada K, Ishida E, Konishi N.
    Histol Histopathol; 2004 Jan 15; 19(1):211-9. PubMed ID: 14702189
    [Abstract] [Full Text] [Related]

  • 9. Primary central nervous system lymphoma in children and adolescents: low relapse rate after treatment according to Non-Hodgkin-Lymphoma Berlin-Frankfurt-Münster protocols for systemic lymphoma.
    Thorer H, Zimmermann M, Makarova O, Oschlies I, Klapper W, Lang P, von Stackelberg A, Fleischhack G, Worch J, Juergens H, Woessmann W, Reiter A, Burkhardt B.
    Haematologica; 2014 Nov 15; 99(11):e238-41. PubMed ID: 25107886
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Primary central nervous system lymphoma.
    Batchelor TT.
    Hematology Am Soc Hematol Educ Program; 2016 Dec 02; 2016(1):379-385. PubMed ID: 27913504
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Multimodality imaging of primary CNS lymphoma in immunocompetent patients.
    Partovi S, Karimi S, Lyo JK, Esmaeili A, Tan J, Deangelis LM.
    Br J Radiol; 2014 Apr 02; 87(1036):20130684. PubMed ID: 24646184
    [Abstract] [Full Text] [Related]

  • 16. Intensive chemotherapy without radiotherapy gives more than 85% event-free survival for non-Hodgkin lymphoma without central nervous involvement: a 6-year population-based study from the nordic society of pediatric hematology and oncology.
    Márky I, Björk O, Forestier E, Jónsson OG, Perkkiö M, Schmiegelow K, Storm-Mathiesen I, Gustafsson G, Nordic Society of Pediatric Hematology and Oncology.
    J Pediatr Hematol Oncol; 2004 Sep 02; 26(9):555-60. PubMed ID: 15342981
    [Abstract] [Full Text] [Related]

  • 17. Primary central nervous system lymphoma.
    DeAngelis LM.
    Recent Results Cancer Res; 1994 Sep 02; 135():155-69. PubMed ID: 8047690
    [No Abstract] [Full Text] [Related]

  • 18. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
    Iványi JL, Marton E, Plander M, Gyánó G, Czumbil L, Tóth C.
    Orv Hetil; 2009 Oct 18; 150(42):1937-44. PubMed ID: 19812012
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.